ReviewOncology research2026

Immunometabolic Reprogramming in Hepatocellular Carcinoma Mechanisms, Biomarkers, and Therapeutic Implications.

Guodong Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.